Compounds > physostigmine
Page last updated: 2024-08-17

physostigmine and Amyotrophic Lateral Sclerosis

physostigmine has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elias, L; Fallat, RJ; Norris, FH; Tan, Y1
Aquilonius, SM; Askmark, H; Eckernäs, SA; Gillberg, PG; Hilton-Brown, P; Rydin, E; Stålberg, E1

Trials

2 trial(s) available for physostigmine and Amyotrophic Lateral Sclerosis

ArticleYear
Trial of oral physostigmine in amyotrophic lateral sclerosis.
    Clinical pharmacology and therapeutics, 1993, Volume: 54, Issue:6

    Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Double-Blind Method; Humans; Nausea; Physostigmine; Placebos

1993
Cholinesterase inhibitors lack therapeutic effect in amyotrophic lateral sclerosis. A controlled study of physostigmine versus neostigmine.
    Acta neurologica Scandinavica, 1986, Volume: 73, Issue:6

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Evoked Potentials; Female; Humans; Isometric Contraction; Male; Middle Aged; Neostigmine; Physostigmine; Reflex

1986